VSI June 2024 Newsletter
Bibliography and Sources

Atas, Hatice, and Müzeyyen Gönül. Increased Risk of Metabolic Syndrome in Patients with Vitiligo. Balkan medical journal vol. 34,3 (2017): 219-225. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5450861/

Colucci, R et al. Oxidative stress and immune system in vitiligo and thyroid diseases. Oxidative Medicine and Cellular Longevity. Vol. 2015:2015 > PMC4370195. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4370195/

Cristal-Lilov A, Salmon A, Erez O, Salmon G. Mental and Physiological Structures and Mechanisms of Overprotection in the Aetiology of Autoimmune Disease. J Med-Clin. Res & Rev. 2021: 5(8): 1-14.

Early J. Conventional, Integrative, and Functional Medicine: What’s the Difference and Which is Right for You? SteadyMD.com. Reviewed by Dr. Dani Urcuyo. 2020 Dec 8. https://www.steadymd.com/blog/conventional-integrative-and-functional-medicine-whats-the-difference-and-which-is-right-for-you/

Hu Z, Tao W. Beyond skin white spots: Vitiligo and associated comorbidities. Frontiers in Medicine. Vol.10 1072837. 23 Feb. 2023. https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9995999/

Hyman M. Why Treating your Symptoms is a Recipe for Disaster. DrHyman.com. 2010 July 18. https://drhyman.com/blog/2010/07/18/why-treating-your-symptoms-is-a-recipe-for-disaster/

Johns Hopkins Medicine. Metabolic Syndrome. Hopkins Medicine.org. https://www.hopkinsmedicine.org/health/conditions-and-diseases/metabolic-syndrome

Mayo Clinic Staff. Metabolic Syndrome. Mayo Clinic.com. 2021 May 6.

MedlinePlus. Vitiligo. Medline Plus.gov. Last updated 2022 Feb 24. https://medlineplus.gov/genetics/condition/vitiligo/

NCOA: Chronic vs. Acute Medical Conditions: What’s the Difference?. National Council on Aging. 2024 Feb 15.https://www.ncoa.org/article/chronic-versus-acute-disease

Osteopathic Center for Healing. How Functional and Conventional Medicine Differ. Blog. https://www.drneilspiegel.com/blog/how-functional-and-conventional-medicine-differ

Renert-Yuval, Yael et al. “Expert Recommendations on Use of Topical Therapeutics for Vitiligo in Pediatric, Adolescent, and Young Adult Patients.” JAMA dermatology vol. 160,4 (2024): 453-461.

Rugge B, Balshem H, Sehgal R, et al. Screening and Treatment of Subclinical Hypothyroidism or Hyperthyroidism. Agency for Healthcare Research and Quality Comparative Effectiveness Reviews: Introduction. No. 24. 2011 October. https://www.ncbi.nlm.nih.gov/books/NBK83492/

Smith T.  Research Suggests Increased Risk for Metabolic Syndrome for Vitiligo Patients. HCPLive.com. 2022 Nov 1. https://www.hcplive.com/view/research-increased-risk-metabolic-syndrome-vitiligo-patients

Stojanovich L, Marisavljevich D. Stress as a trigger of autoimmune disease. Autoimmunity Reviews. Vol. 7,3 (2008): 209-13. https://pubmed.ncbi.nlm.nih.gov/18190880/

The Institute for Functional Medicine. Mark Hyman, MD. https://www.ifm.org/about/profile/mark-hyman/

WebMD. Proactive Healthcare: Moving Away from Reactive Care Models. WebMD Ignite. 2018 May 14. https://webmdignite.com/blog/reactive-vs-proactive-healthcare-models

Vojdani A. A Potential Link between Environmental Triggers and Autoimmunity. Autoimmune Diseases. Volume 2014, Article ID 437231, 18 pp. Published 2014 Feb 12. https://www.hindawi.com/journals/ad/2014/437231/

Yassaee A. Shifting the dial from reactive to proactive healthcare. Huma.com. Blog. 2023 Feb 21. https://www.huma.com/resources/reactive-to-proactive-healthcare

Copyright © 2024 Vitiligo Support International Inc. All rights reserved.
Reproduction or republication strictly prohibited without prior written permission.

A Vitiligo Support International, Inc. financial statement is available upon written request from the Virginia Office of Consumer Affairs. Mail requests to: Virginia Department of Agriculture and Consumer Services, Office of Consumer Affairs, P.O. Box 1163, Richmond, Virginia 23218.